天康生物20251113

Summary of JinKang Biological Conference Call Company Overview - JinKang Biological is a comprehensive agricultural enterprise involved in oil processing, corn procurement, pig farming, feed production, and veterinary biological products [2][3] - Established in 2000, the company has over 50 large-scale breeding bases across China and ranks among the top 20 in the domestic pig farming industry [3] Key Financial Metrics - In 2024, JinKang is expected to have a pig output of 3.03 million heads, with feed sales of 2.83 million tons and veterinary business revenue of 990 million yuan [2] - The gross profit contributions for 2024 are as follows: - Pig farming: 900 million yuan (46%) - Feed business: 580 million yuan (30%) - Veterinary business: 620 million yuan (24%) [2][5] - The company reported a net loss of 1.363 billion yuan in 2023 due to pig price fluctuations, but performance is expected to improve in 2024 [2][5] - The projected net profit for 2024 is approximately 600 million yuan, with an expected decrease to 500 million yuan in 2025 [4][9] Industry Context - The industry is currently at the bottom of the cycle, expected to last until mid-2026, with a recovery anticipated in the second half of 2026 [2][8] - The duration of industry losses and the degree of capacity reduction are key indicators for recovery [8] Competitive Advantages - JinKang Biological has three core competitive advantages: 1. Integrated operational model leading to stable performance and a lighter asset-liability structure [6][7] 2. Geographic advantages with production concentrated in Xinjiang, Gansu, and Henan, providing low-density farming environments and biosecurity [7] 3. Strong cost control, with total comprehensive costs expected to decrease from 15 yuan per kg to 13.5 yuan by the end of 2024, and further to 12 yuan by Q3 2025 [7] Valuation and Investment Potential - The current price-to-earnings (P/E) ratio is approximately 17, significantly lower than the industry average of 33, indicating potential for value investment [4][9] - Factors supporting investment in JinKang include the upcoming industry recovery, stable operational model, core competitive advantages, and undervalued market position [9]